Table S7 from Catalytic Inhibition of p300 Preferentially Targets IRF4 Oncogenic Activity and Tumor Growth in Multiple Myeloma

2026 Open access

Read full text
Authors: W. Frank Lenoir, Michael R. McKeown, Giulia Giorgetti, Marek J. Kobylarz, Tamara D. Hopkins, Wayne L. Glore, Michelle G. Shum, Yaretzi Calderón, Jessica Encinas, Luis A. Carvajal, Kameron R. Mori, Jun Li
+11 more Hua Gao, Yupeng Zheng, Zhihua Ma, Nikolaus D. Obholzer, Minyun Zhou, Benjamin Wesley Trotter, Christopher J. Dinsmore, Nikhil C. Munshi, Charles Y. Lin, Mariateresa Fulciniti, Peter B. Rahl
DOI: 10.1158/0008-5472.31345613
Cited by: 0

Abstract

EnhancerPromoter ChIP AUC output for IRF4, p300, and H3K27ac in MM1.S, as well as other omic metrics used for heatmap within Figure 3E.

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Genomics and Chromatin Dynamics Chromatin Remodeling and Cancer

Publication details

Publication date
16 February 2026
Language
EN